Africa Day at Novartis highlights the continent’s healthcare needs and efforts to address them.
Patients with multiple sclerosis, an autoimmune disease that affects 2.5 million worldwide, lose brain volume three to five times faster than people without the disease.
Morning is the most challenging time of day for many patients with COPD, who may have shortness of breath, coughing and difficulty getting ready.
More than 125 million people globally live with psoriasis, a chronic autoimmune disease that causes red, scaly patches to appear on the skin.
The incidence of leprosy, an infectious disease that causes lumps and skin sores, has decreased by roughly 95%, but 233,000 new cases were reported in 2012.
Professor Klaus M. Leisinger is stepping down as Chairman of the Board of the Novartis Foundation for Sustainable Development (NFSD). Dr. Andrin Oswald will take on an additional role as Chairman of the Board overseeing the NFSD.
Malaria programs in sub-Saharan Africa are making progress by using insecticide-treated nets, diagnostic testing and Artemisinin-based Combination Therapy.
More than 1.5 million healthcare workers, including nurses and birthing attendants, are needed in Africa. The continent has 24% of the world’s disease burden.
Acute heart failure (AHF) is a condition where the heart cannot pump enough blood around the body. Each year 3.5 million AHF episodes occur in the US and EU.
Novartis BioCamp gives students new perspectives on healthcare challenges.
Review the strategy and annual performance of Novartis and read letters from our Chairman and CEO.
For media and journalist inquiries, please contact the Novartis Corporate Media Relations office by email or telephone.
Central Media Line:Phone: +41 61 324 2200
This site is intended for a global audience.